Upregulation of cytochrome P450 1A2 in chronic renal failure: Does oxidized tryptophan play a role?

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 401-407

  Sindhu, Ram K ^a   Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME REGULATION; GENETIC TRANSCRIPTION; INTERMETHOD COMPARISON; KIDNEY PARENCHYMA; LIVER; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE HOMOGENATE;

ANIMALIA;

EID: 1042302734     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_47     Document Type: Conference Paper

References (39)

1. F.J. Gonzalez, The molecular biology of cytochrome P450s, Pharmacol. Rev. 40, 243-288 (1989).
2. F.P. Guengerich, T. Shimada, Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes, Chem. Res. Toxicol. 4, 391-407 (1991).
3. M.E. McManus, R.F. Minchin, N. Sanderson, D. Schwartz, E.F. Johnson, S.S. Thoreirsson, Metabolic processing of 2-acetylaminofluorene by microsomes and six highly purified cytochrome P450 forms from rabbit liver, Carcinogenesis 5, 1717-1723 (1984).
4. F.F. Kadlubar, G.J. Hammons, The role of cytochrome P450 in the metabolism of chemical carcinogens. in: Mammalian cytochrome P450, edited by F.P. Guengerich, vol.1 (CRC Press, Boca Raton. 1987). pp. 1-54.
5. M.B. Faletto, P.L. Koser, N. Battula, G.K. Townsend, A.E. Maccubbin, H.V. Gelboin, H.L. Gurtoo. Cytochrome P3-450 cDNA encodes aflotoxin B1-4-hydroxylase, J. Biol. Chem. 263, 12187-12189 (1988).
6. T. Okamoto, M. Mitsuhashi, I. Fujita, R.K. Sindhu, Y. Kikkawa, Induction of cytochrome P450 1A1 ans 1A2 by hyperoxia, Biochem. Biophys. Res. Commun. 197, 878-885 (1993).
7. O.G. Khatsenko, R.K. Sindhu, Y. Kikkawa, Undernutrition during hyperoxic exposure induces CYP2E1 in rat liver, Arch. Toxicol. 71, 684-689 (1997).
8. R.K. Sindhu, H. Sakai, Y. Kikkawa, Effect of hyperoxia on rat pulmonary and hepatic cytochrome P450 monooxygenases, Arch. Toxicol. 73, 540-546 (2000).
9. R.K. Sindhu, S. Reisz-Porszasz, O. Hankinson, Y. Kikkawa, Induction of cytochrome P450 1A1 by photooxidized tryptophan in Hepa lclc7 cells, Biochemical Pharmacology 52, 1883-1893 (1996).
10. R.K. Sindhu, Y. Kikkawa, Superinduction of oxidized tryptophan inducible cytochrome P450 1A1 by cycloheximide in Hepa lclc7 cells, In Vitro Mol. Toxicol. 73, 149-162 (1999).
11. R.K. Sindhu, R.E. Rasmussen, Y. Kikkawa, Induction of cytochrome P450 1A1 by ozone-oxidized tryptophan in Hepa lclc7 cells, Adv. Exptl. Med. Biol. 467, 409-418 (1999).
12. R.K. Sindhu, M. Mitsuhashi, Y. Kikkawa, Induction of cytochrome P450 1A2 by oxidized tryptophan in Hepa lclc7 cells, J. Pharmacol. Exptl. Ther. 292, 1008-1014 (2000).
13. F.P. Guengerich, T. Shimada, Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes, Chem. Res. Toxicol. 4, 391-407 (1991).
14. S.A. Wrighton, J.C. Stevens, The human hepatic cytochromes P450 involved in drug metabolism. Critical Rev. Toxicol. 22, 1-21 (1992).
15. G. Silver, K.S. Krauter, Expression of cytochrome P450c and P450d mRNA in cultured rat hepatocytes. 3-Methylcholanthrene induction is regulated primarily at the post-transcriptional level. J. Biol. Chem. 263, 11802-11807 (1988).
16. K. Saito, S. Fujigaki, M.P. Heyes, K. Shibata, M. Takemura, H. Fujii, H. Wada, A. Nomo, M. Seishima, Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am. J. Physiol. Renal Physiol. 279, F565-F572 (2000).
17. N.D. Vaziri, Z. Ni, X.Q. Wang, F. Oveisi, X.J. Zhou, Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH, Am. J. Physiol. Renal Physiol. 274, 642-649 (1998).
18. O. Hankinson, The aryl hydrocarbon receptor complex, Annu. Rev. Pharmacol. Toxicol. 35, 307-340 (1995).
19. L.C. Quattrochi, T. Vu, R.H. Tukey, The human CYP1A2 gene and induction by 3-methylcholantrene: A region of DNA that supports Ah receptor binding and promoter-specific induction, J. Biol. Chem. 269, 6949-6954 (1994).
20. R.C. Chowdhury, N.R. Chowdhury, A.W. Wolkoff, I.M. Arias, Heme and bile pigment metabolism, in: The Liver: Biology and Pathology, edited by I.M. Arias, J.L. Boyer, N. Fausto, W.B. Jakoby, D.A. Schachter, D.A. Schafritz (Raven Press, New York, 1994), pp. 471-504.
21. M.D. Maines, Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications, FASEB J. 2, 2557-2568 (1988).
22. K.A. Nath, G. Balla, G.M. Vercellotti, J. Balla, H.S. Jacob, M.D. Levitt, M.E. Rosenberg, Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat, J. Clin. Invest. 90, 267-270 (1992).
23. T. Iyanagi, T. Watanabe, Y. Uchiyama, The 3-methylcholanthrene-inducible UDP-glucuronosyltranferase defficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a-1 frameshift mutation, J. Biol. Chem. 264, 21302-21307 (1989).
24. J. Kapitulnik, J.D. Ostrow, Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed-function monooxygenases, Proc. Natl. Acad. Sci. U.S.A. 75, 682-685 (1978).
25. F. De Matteis, T. Trenti, A.H. Gibbs, J.B. Greig, Inducible bilirubin-degrading system in the microsomal fraction of rat liver, Mol. Pharmacol. 35, 831-838 (1989).
26. J. Kapitulnik, F. Gonzalez, Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat, Mol. Pharmacol. 43, 722-725 (1993).
27. C.J. Sinal, J.R. Bend, Aryl hydrocarbon receptor-dependent induction of Cyp1a1 by bilirubin in mouse hepatoma lclc7 cells, Mol. Pharmacol. 52, 590-599 (1997).
28. D. Phelan, G.M. Winter, W.J. Rogers, J.C. Lam, M.S. Denison, Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin, Arch. Biochem. Biophys. 357, 155-163 (1998).
29. N.D. Vaziri, Z. Ni, F. Oveisi, K. Liang, R. Pandian, Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency, Hypertension 39, 135-41 (2002).
30. H.V. Gelboin, Benzo[a]pyrene metabolism, activation and carcinogenesis: Role and regulation of mixed-function oxidases and related enzymes, Pharmacol. Rev. 60, 1107-1166 (1980).
31. P. Ball, R. Knuppen, Catecol oestrogen (2-and 4-hydroxyestrogens): Chemistry, biogenesis, metabolism, occurance and physiological significance, Acta Endocrinol. 93 (suppl.) 232, 1-127 (1980).
32. D. Stack, J. Byun, M.L. Gross, E.G. Rogan, E.L. Cavalieri, Molecular characteristics of catecol estrogen quinines in reactions with deoxyribonucleosides, Chem. Res. Toxicol. 9, 851-859 (1996).
33. E.L. Cavalieri, D.E. Stack, P.D. Devanesan, R. Todorovic, I. Dwivedy, S. Higginbotham, S.L. Johansson, K.D. Patil, M.L. Gross, J.K. Gooden, R. Ramanathan, R.L. Cerny, E.G. Rogan, Molecular origin of cancer: Catecol estrogen-3,4-quinones as endogenous tumor initiators, Proc. Natl. Acad. Sci. U.S.A. 94, 10937-10942 (1997).
34. 2-3,4-quinone with DNA. Proc. Am. Assoc. Cancer Res. 39, 636 (1998).
35. M.V. Pahl, N.D. Vaziri, In: Handbook of dialysis, edited by J.T. Daugirdas, T.S. Ing, second edition (Little Brown Publisher, Boston, 1994), pp. 537-544.
36. M.J. Thirman, J.H. Albrecht, M.A. Krueger, R.R. Erickson, D.L. Cherwitz, S.S. Park, H.V. Gelboin, J.L. Holtzman, Induction of CYP1A1 and formation of toxic metabolites of benzopyrene by rat aorta: A possible role in atherogenesis, Proc. Natl. Acad. Sci. U.S.A. 91, 5297-5401 (1994).
37. S.I. Hogg, A. Cryer, Aortic arylhydrocarbon hydroxylase activity atherosclerosis-susceptible species. Comp. Biochem. Physiol. 73B, 669-671 (1982).
38. B. Paigen, P.A. Hlomes, A. Morrow, D. Mitchell, Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors, Cancer Res. 46, 3321-3324 (1986).
39. A. Penn, C. Snyder, Arteriosclerotic plaque development is promoted by polynuclear aromatic hydrocarbons, Carcinogenesis 9, 2185-2189 (1988).